“We are thrilled to welcome Dr. Mychaskiw who brings with him extensive academic, clinical and research experience,” said Richard V. Homan, M.D., senior vice president for health affairs and Annenberg Dean of Drexel University College of Medicine. “We look forward to supporting his continuing contributions in the advancement of new pain management techniques.”Throughout his career, Mychaskiw has distinguished himself in the practice of pediatric and adult anesthesiology. Mychaskiw is specifically knowledgeable in the areas of complex heart, thoracic and major vascular cases in children. He has a special interest in local anesthetic medicines for acute pain management following heart and chest surgery.
“Dr. Mychaskiw has a wealth of expertise as a clinician, educator, and physician executive. He is widely regarded throughout the country as a leader in the field of anesthesiology. We could not be more pleased to have him join the Hahnemann medical staff,” stated Michael P. Halter, FACHE, chief executive officer, Hahnemann University Hospital.During his time at the University of Mississippi Blair E. Batson Children’s Hospital, Mychaskiw founded the Hyperbaric Research Center, studying the medical use of oxygen at a level higher than atmospheric pressure. Mychaskiw’s career began in academic practice at Yale, followed by a stint in private practice in Greenville, Mississippi. From there, he became chief operating officer of the largest physician anesthesiology group in the state. He was also chair of anesthesiology at Delta Regional Medical Center, a tertiary care hospital. In addition, he spent much of his time in the critical care management of children at the Mississippi Firefighter’s Memorial Burn Center, one of the largest burn units in the Southeast. The Center covered six hospitals in two states, with a combined 750 bed total.
After recently completing the American Osteopathic Association Health Policy Fellowship, Mychaskiw became increasingly involved in the development of health guiding principals. “My primary interest in health policy is the distribution and utilization of physician and allied health strength, diversity and culturally competent care in the workforce, along with increasing access to affordable medical education to underrepresented populations,” says Mychaskiw. He worked with the United States Congress in the study of these issues.
He attended medical school at the University of Health Sciences College of Osteopathic Medicine in Kansas City, Mo., and completed a residency in Anesthesiology at the Yale University School of Medicine in New Haven, Conn. Mychaskiw also completed fellowships in cardiac and pediatric anesthesiology at Yale and was appointed as an assistant professor of anesthesiology in the cardiac and pediatric divisions at the Yale New Haven Hospital. He has also received training in hyperbaric medicine at the University of Texas, Galveston.
Mychaskiw is certified by the American Board of Anesthesiology and the National Board of Echocardiography. He is the author of numerous articles and book chapters and has been a visiting professor at many academic institutions in the US, Canada, the Philippines and Saudi Arabia. Mychaskiw is on several editorial boards and serves as editor-in-chief for the Journal of Undersea and Hyperbaric Medicine. In addition, he is a recipient of the Stover-Link Award for outstanding contributions to hyperbaric medicine.
Hahnemann University Hospital is a 540-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. In 2009, Hahnemann earned Magnet® designation by the American Nurses Credentialing Center (ANCC) Magnet Recognition Program®. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments. The hospital performed one of the city’s first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia’s first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation’s oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher’s Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com
About Drexel University College of Medicine
Drexel University College of Medicine has established some of the most highly innovative and rigorous academic programs available today, incorporating the University’s expertise in engineering and technology into traditional medical training. The College of Medicine is home to one of the nation’s leading centers for spinal cord research; one of the foremost centers for malaria study; and a highly regarded HIV/AIDS program with extensive NIH-funded research in prevention and therapeutic interventions. Drexel University College of Medicine has been designated a Vanguard National Center of Excellence in Women’s Health by the U.S. Department of Health & Human Services, and is highly respected in numerous other specialties including autism, cardiology, minimally invasive surgery, and toxicology. Visit www.drexelmed.edu for more information.
Terms And Conditions
Notice of Privacy Practices
Hahnemann University Hospital | 230 N Broad St, Philadelphia, PA 19102
© 2002-2013 Tenet HealthSystem Hahnemann, LLC, All Rights Reserved.